Medicinal Cannabis Market Size In 2022 Reaching USD 73952.26 million by 2027

3.7 min readPublished On: November 17th, 2022By

PUNE – “Medicinal Cannabis Market” research report focus on overall information that can help to take decisions on current market situation. Medical cannabis is cannabis and cannabinoids that are recommended by doctors for their patients.The use of cannabis as medicine has not been rigorously tested due to production restrictions and other governmental regulations.

Medicinal Cannabis Market Report Contains: –

  • Complete overview of the global Medicinal Cannabis Market
  • The global Medicinal Cannabis market size was valued at USD 25238.54 million in 2021 and is expected to expand at a CAGR of 19.62% during the forecast period, reaching USD 73952.26 million by 2027.
  • Top Country data and analysis for United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Medicinal Cannabis markets such as North America, Europe, Asia-Pacific, South America and Middle East and Africa
  • Description and analysis of Medicinal Cannabis market potential by type, Deep Dive, disruption, application capacity, end use industry
  • impact evaluation of most important drivers and restraints, and dynamics of the global Medicinal Cannabis market and current trends in the enterprise
  • Detailed profiles of the Top major players in the industry, including. Aurora Cannabis, Inc.,Cronos Group,Chemesis International,Medical Marijuana Inc.,BOL Pharma,Khiron life Sciences,GW Pharmaceuticals, plc,Aphria, Inc.,Canntab Therapeutics Limited,Insys Therapeutics, Inc.,Green Organic Dutchman,Medreleaf Corporation,MGC Pharmaceuticals Limited,Canopy Growth Corporation,Tilray

Medicinal Cannabis Market Segmentation: 

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Medicinal Cannabis market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Researcher’s latest report provides a deep insight into the global Medicinal Cannabis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

Medicinal Cannabis Market segments help decision-makers direct the product, sales, and marketing strategies, and can power your product development cycles by informing how you make product offerings for different segments.

In Chapter 5 and Chapter 7.3, based on types, the Medicinal Cannabis market from 2017 to 2027 is primarily split into:

  • Tetrahydrocannabinol (THC)
  • Cannabidiol (CBD)

In Chapter 6 and Chapter 7.4, based on applications, the Medicinal Cannabis market from 2017 to 2027 covers:

  • Pain
  • Arthritis
  • Neurological Disease
  • Others

Market segment by Region/Country including: –

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain, etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia, Southeast Asia, etc.)
  • South America (Brazil, Argentina, Colombia, etc.)
  • Middle East & Africa (South Africa, UAE, Saudi Arabia, etc.)

Key Players in the Medicinal Cannabis Market: –

  • Aurora Cannabis, Inc.
  • Cronos Group
  • Chemesis International
  • Medical Marijuana Inc.
  • BOL Pharma
  • Khiron life Sciences
  • GW Pharmaceuticals, plc
  • Aphria, Inc.
  • Canntab Therapeutics Limited
  • Insys Therapeutics, Inc.
  • Green Organic Dutchman
  • Medreleaf Corporation
  • MGC Pharmaceuticals Limited
  • Canopy Growth Corporation
  • Tilray

Key Benefits of Medicinal Cannabis Market Research Report:

  • Types, applications, regions, and key players covered in the study
  • Industry drivers, restraints, and opportunities covered in the study
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Artificial Intelligence AI Chips Market
  • Sales, price, revenue, market share, and growth rate are covered in the report sales channels, distributors, traders, dealers, etc. are covered in the report

(This information is primarily sourced from Proficient Market Insights.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News